Vimarsana
Biggest News Aggregation in the World

Onsite Plenary News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Onsite Plenary. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Onsite Plenary Today - Breaking & Trending Today

Qynapse to present symposium oral and poster presentations at AD/PD™ 2022 International Conference - Vimarsana News

Qynapse to present symposium oral and poster presentations at AD/PD™ 2022 International Conference

/PRNewswire/ -- Qynapse SAS, a medical technology company commercializing an FDA approved/CE cleared AI-powered neuroimaging software platform for central...

QYNAPSE: Qynapse to present symposium oral and poster presentations at AD/PD 2022 International Conference - Vimarsana News

QYNAPSE: Qynapse to present symposium oral and poster presentations at AD/PD 2022 International Conference

BOSTON, March 3, 2022 /PRNewswire/ -- Qynapse SAS, a medical technology company commercializing an FDA approved/CE cleared AI-powered neuroimaging software platform for central nervous system

Qynapse to present symposium oral and poster presentations at AD/PD™ 2022 International Conference - Vimarsana News

Qynapse to present symposium oral and poster presentations at AD/PD™ 2022 International Conference

/PRNewswire/ -- Qynapse SAS, a medical technology company commercializing an FDA approved/CE cleared AI-powered neuroimaging software platform for central...

Qynapse to present symposium oral and poster presentations at AD/PD™ 2022 International Conference - Vimarsana News

Qynapse to present symposium oral and poster presentations at AD/PD™ 2022 International Conference

/PRNewswire/ -- Qynapse SAS, a medical technology company commercializing an FDA approved/CE cleared AI-powered neuroimaging software platform for central...

AC Immune to Present at the AD/PD™ 2022 New Clinical and Preclinical Data for Alpha-Synuclein, Abeta and TDP-43 Programs - Vimarsana News

AC Immune to Present at the AD/PD™ 2022 New Clinical and Preclinical Data for Alpha-Synuclein, Abeta and TDP-43 Programs

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com